Literature DB >> 30617195

Anti-human CD117 antibody-mediated bone marrow niche clearance in nonhuman primates and humanized NSG mice.

Hye-Sook Kwon1, Aaron C Logan2, Akanksha Chhabra1, Wendy W Pang1, Agnieszka Czechowicz3,4,5, Keri Tate6, Alan Le1, Jessica Poyser1, Roger Hollis7, Benjamin V Kelly8, Donald B Kohn7,9, Irving L Weissman4,10,11,12, Susan S Prohaska1, Judith A Shizuru1,3,10,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30617195      PMCID： PMC6509543          DOI： 10.1182/blood-2018-06-853879

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  23 in total

1.  Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.

Authors:  Xingkui Xue; Nancy K Pech; W Christopher Shelley; Edward F Srour; Mervin C Yoder; Mary C Dinauer
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

Review 2.  Hematopoietic stem and progenitor cells: clinical and preclinical regeneration of the hematolymphoid system.

Authors:  Judith A Shizuru; Robert S Negrin; Irving L Weissman
Journal:  Annu Rev Med       Date:  2005       Impact factor: 13.739

Review 3.  c-Kit--a hematopoietic cell essential receptor tyrosine kinase.

Authors:  Charlotte E Edling; Bengt Hallberg
Journal:  Int J Biochem Cell Biol       Date:  2007-01-20       Impact factor: 5.085

Review 4.  The road to purified hematopoietic stem cell transplants is paved with antibodies.

Authors:  Aaron C Logan; Irving L Weissman; Judith A Shizuru
Journal:  Curr Opin Immunol       Date:  2012-08-29       Impact factor: 7.486

5.  A distinct hematopoietic stem cell population for rapid multilineage engraftment in nonhuman primates.

Authors:  Stefan Radtke; Jennifer E Adair; Morgan A Giese; Yan-Yi Chan; Zachary K Norgaard; Mark Enstrom; Kevin G Haworth; Lauren E Schefter; Hans-Peter Kiem
Journal:  Sci Transl Med       Date:  2017-11-01       Impact factor: 17.956

6.  Isolation of c-kit receptor-expressing cells from bone marrow, peripheral blood, and fetal liver: functional properties and composite antigenic profile.

Authors:  T Papayannopoulou; M Brice; V C Broudy; K M Zsebo
Journal:  Blood       Date:  1991-09-15       Impact factor: 22.113

7.  Anti-CD117 antibody depletes normal and myelodysplastic syndrome human hematopoietic stem cells in xenografted mice.

Authors:  Wendy W Pang; Agnieszka Czechowicz; Aaron C Logan; Rashmi Bhardwaj; Jessica Poyser; Christopher Y Park; Irving L Weissman; Judith A Shizuru
Journal:  Blood       Date:  2019-02-11       Impact factor: 25.476

8.  The effect of bleeding on hematopoietic stem cell cycling and self-renewal.

Authors:  Samuel H Cheshier; Susan S Prohaska; Irving L Weissman
Journal:  Stem Cells Dev       Date:  2007-10       Impact factor: 3.272

Review 9.  Expression of the c-kit (CD117) molecule in normal and malignant hematopoiesis.

Authors:  L Escribano; M Ocqueteau; J Almeida; A Orfao; J F San Miguel
Journal:  Leuk Lymphoma       Date:  1998-08

10.  Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Authors:  Agnieszka Czechowicz; Daniel Kraft; Irving L Weissman; Deepta Bhattacharya
Journal:  Science       Date:  2007-11-23       Impact factor: 47.728
View more
  29 in total

1.  Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells.

Authors:  Renier Myburgh; Jonathan D Kiefer; Norman F Russkamp; Chiara F Magnani; Nicolás Nuñez; Alexander Simonis; Surema Pfister; C Matthias Wilk; Donal McHugh; Juliane Friemel; Antonia M Müller; Burkhard Becher; Christian Münz; Maries van den Broek; Dario Neri; Markus G Manz
Journal:  Leukemia       Date:  2020-05-01       Impact factor: 11.528

Review 2.  Gene therapy using haematopoietic stem and progenitor cells.

Authors:  Giuliana Ferrari; Adrian J Thrasher; Alessandro Aiuti
Journal:  Nat Rev Genet       Date:  2020-12-10       Impact factor: 53.242

Review 3.  Humanized mouse model: a review on preclinical applications for cancer immunotherapy.

Authors:  Ling Yin; Xue-Jing Wang; De-Xi Chen; Xiao-Ni Liu; Xiao-Jun Wang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 4.  The influence of environment and origin on brain resident macrophages and implications for therapy.

Authors:  Mariko L Bennett; F Chris Bennett
Journal:  Nat Neurosci       Date:  2019-12-02       Impact factor: 24.884

5.  Antibody-drug conjugates plus Janus kinase inhibitors enable MHC-mismatched allogeneic hematopoietic stem cell transplantation.

Authors:  Stephen P Persaud; Julie K Ritchey; Sena Kim; Sora Lim; Peter G Ruminski; Matthew L Cooper; Michael P Rettig; Jaebok Choi; John F DiPersio
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

6.  Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow.

Authors:  Huy Q Dinh; Tobias Eggert; Melissa A Meyer; Yanfang Peipei Zhu; Claire E Olingy; Ryan Llewellyn; Runpei Wu; Catherine C Hedrick
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

7.  Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development.

Authors:  Paula Cannon; Aravind Asokan; Agnieszka Czechowicz; Paula Hammond; Donald B Kohn; Andre Lieber; Punam Malik; Peter Marks; Matthew Porteus; Els Verhoeyen; Drew Weissman; Irving Weissman; Hans-Peter Kiem
Journal:  Hum Gene Ther       Date:  2021-01       Impact factor: 5.695

Review 8.  CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.

Authors:  Olivier Humbert; Clare Samuelson; Hans-Peter Kiem
Journal:  Br J Haematol       Date:  2020-06-07       Impact factor: 6.998

Review 9.  Human inborn errors of immunity: An expanding universe.

Authors:  Luigi D Notarangelo; Rosa Bacchetta; Jean-Laurent Casanova; Helen C Su
Journal:  Sci Immunol       Date:  2020-07-10

10.  Non-genotoxic conditioning facilitates hematopoietic stem cell gene therapy for hemophilia A using bioengineered factor VIII.

Authors:  Athena L Russell; Chengyu Prince; Taran S Lundgren; Kristopher A Knight; Gabriela Denning; Jordan S Alexander; Jaquelyn T Zoine; H Trent Spencer; Shanmuganathan Chandrakasan; Christopher B Doering
Journal:  Mol Ther Methods Clin Dev       Date:  2021-05-05       Impact factor: 6.698
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.